Pregnancy Medication Market Size & Share 2023 to 2032
Market Size by Drug Class (Antianemia, Antacids, Antiallergic, Analgesics, Antimicrobials, Hormones, Laxatives, Vaccines, Nutritional Supplements {Minerals, Omega 3}), by Pregnancy Stage, by Distribution Channel & Forecast.
Report ID: GMI5385
|
Published Date: October 2022
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Pregnancy Medication Market Size
Pregnancy Medication Market size was valued at over USD 33 billion in 2022 and is poised to witness 13% CAGR from 2023 to 2032.
Rapid development in incidences of pregnancy-associated complications is expected to drive the demand for pregnancy medication. Based on estimates by the World Health Organization, every day, almost 800 women worldwide die due to complications during childbirth. These intricacies are 36 times more prevalent in developing economies than in developed countries. The alarming progress in childbirth-related complications can be attributed to improper dietary habits, physical inactivity, and the rising adoption of a sedentary lifestyle.
Consumption of unhealthy food during pregnancy can increase the risk of developing various long-term irreversible health issues. These may range from high blood pressure, cholesterol, heart diseases, and type 2 diabetes to defective childbirth. The rapid inclination toward maintaining a proper nutritional diet rich in all micro and macronutrients to support the health of the mother and the fetus will create positive growth prospects for the pregnancy medication industry.
Pregnancy Medication Market Trends
The intake of other medications and the possible side effects and health risks associated with them may limit the pregnancy medication market value. A significant share of pregnant women consumes over-the-counter drugs for several comorbidities, such as CVDs, which are one of the leading causes of death among pregnant women. These medications may also lead to premature birth, low birth weight, stillbirth, and other complications, which may downsize the market share.
Pregnancy Medication Market Analysis
Pregnancy medication market from nutritional supplements segment garnered revenues worth over USD 16.5 billion in 2022. Nutritional supplements comprising omega-3, vitamins, minerals, folic acid, multivitamins, and others support the development of the placenta and fetus while preventing the risk of neural tube defects. The growing emphasis on maintaining a healthy diet to minimize the prospects of birth defects and improper nutrition in babies will propel the segment size.
The 2nd-trimester segment is expected to exhibit over 13% CAGR from 2023 to 2032. The intake of pregnancy medications and supplements in the 2nd-trimester improves sensory gating and reduces the risk of later attention deficits and psychological disorders. Health complications such as separation of the placenta from the uterus, increased preterm labor, and other risk factors are quite prevalent during the 4th to 6th months of pregnancy. Hence, in light of these complications, the pregnancy medication demand will accelerate throughout the projection period.
Pregnancy medication market from retail pharmacy segment is anticipated to amass nearly 28% business share by 2032. Retail pharmacies are easily accessible to patients and have the availability of a broad range of healthcare products and everyday items. These establishments are equipped with skilled pharmacists offering uniquely tailored personalized advice to patients based on their health issues. Access to high-quality consumer service at affordable prices across these settings will help retail pharmacies emerge as major expansion contributors in the ensuing years.
Europe pregnancy medication market is slated to cross USD 23 billion by 2032. The increasing number of market participants organizing social media campaigns and health initiatives to create awareness about proper health and diet among pregnant women will stimulate the regional market landscape. In addition, the growing incidences of birth defects and congenital anomalies, coupled with the availability of high-quality health supplements, will positively influence the industry dynamics across Europe.
Pregnancy Medication Market Share
Major companies participating in the pregnancy medication industry are
These players have been adopting brand acquisitions, mergers, and collaboration as part of their key growth strategy.
For instance, in June 2022, Glenmark Pharmaceuticals Ltd. and its U.S. subsidiary announced the acquisition of Wockhardt Ltd.'s generic interpretations of 4 OTC drugs. The move designated the continued expansion of the firm's over-the-counter business in the U.S., comprising vitamins, minerals, and other products.
Impact of COVID-19 Pandemic
The COVID-19 pandemic had a favorable impact on the pregnancy medication industry. This can be credited to the rapid surge in pregnancies during the crisis and the rising awareness about the benefits of nutritional supplements in child growth and development. Based on a poll conducted by United Nations, several countries such as China, Pakistan, and India have witnessed a visible rise in the number of pregnancies during lockdowns, with nearly 13.5 million, 5 million, and 7 million pregnancies registered during the given period. The increasing sales of prenatal supplements to eliminate prospective childbirth complications may further boost the market outlook.
The pregnancy medication market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Drug Class
By Pregnancy Stage
By Distribution Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →